ezetimibe
generics (uk) limited - ezetimibe - tablets - 10 milligram - ezetimibe
ezetimibe teva 10 mg tablets
teva b.v. - ezetimibe - tablet - 10 milligram(s) - other lipid modifying agents; ezetimibe
ezetimibe/simvastatin teva 10mg/80mg tablets
teva b.v. swensweg 5, 2031 ga haarlem, netherlands - ezetimibe, simvastatin - tablet - ezetimibe 10 mg simvastatin 40 mg - lipid modifying agents
ezetimibe/simvastatin teva 10mg/20mg tablets
teva b.v. swensweg 5, 2031 ga haarlem, netherlands - ezetimibe, simvastatin - tablet - ezetimibe 10 mg simvastatin 20 mg - lipid modifying agents
ezetimibe/simvastatin teva 10mg/40mg tablets
teva b.v. swensweg 5, 2031 ga haarlem, netherlands - ezetimibe, simvastatin - tablet - ezetimibe 10 mg simvastatin 40 mg - lipid modifying agents
ezetimibe tablets 10mg
zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - ezetimibe - tablet - ezetimibe 10 mg - lipid modifying agents
ezetimibe teva tablets 10mg
teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - ezetimibe - tablet - ezetimibe 10 mg - lipid modifying agents
ezetimibe 10mg tablets
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - ezetimibe - tablet - ezetimibe 10 mg - lipid modifying agents
ezetimibe/atorvastatin althera 10 mg/10 mg film-coated tablet
althera laboratories ltd 1st floor, 9 exchange place, i.f.s.c. dublin 1, ireland - ezetimibe, atorvastatin - film-coated tablet - ezetimibe 10 mg atorvastatin 10 mg - lipid modifying agents
ezetimibe taro 10 mg
taro international ltd, israel - ezetimibe - tablets - ezetimibe 10 mg - ezetimibe - primary hypercholesterolemia: ezetimibe taro administered with an hmg-coa reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. homozygous familial hypercholesterolemia (hofh): ezetimibe taro administered with a statin are indicated for use in patients with hofh. patients may also receive adjunctive treatments (e.g. ldl apheresis). homozygous sitosterolemia (phytosterolemia): ezetimibe taro are indicated for use in patients with homozygous familial sitosterolemia.